The Prostate
Investigative RadiologyPublished 1 February 1996
Ronald H. Gottlieb, Cathleen Mooney, Alvin I. Mushlin, Deborah J. Rubens, Patrick J. Fultz
Citations12
SJR quartileQ1
SJR score2.67
SNIP1.98
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Immediate prostate biopsy is not cost-effective and can be detrimental in patients > or = 70 years of age at all excess PSA levels between 0 ng/mL and 20 ng/ mL.
Abstract
Immediate prostate biopsy is not cost-effective and can be detrimental in patients > or = 70 years of age at all excess PSA levels between 0 ng/mL and 20 ng/mL.
Keywords
Medicine
CancerLocalized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer
797 Citations1993Thomas A. Stamey, Fuad S. Freiha +4 more
The authors calculated the probability at birth of having a diagnosis of prostate cancer within a man's life to be 8.8% and subtracted the incidence of microscopic Stage A cancers too small to ever be clinically significant.
JAMAHigh 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer
467 Citations1992Jan‐Erik Johansson
The low disease-specific mortality rate, especially in patients with highly and moderately differentiated tumors, means that any local or systemic therapy intended for patients with early prostatic cancer must be evaluated in clinical trials with untreated controls for comparison.
JAMAWatchful Waiting vs Immediate Transurethral Resection for Symptomatic Prostatism
270 Citations1988Michael J. Barry
It is concluded that patient preferences should be the dominant factor in the decision whether to recommend prostatectomy, and immediate surgery was favored with a net utility benefit when adjustments were made for quality of life.
The Journal of UrologyRate of Change in Serum Prostate Specific Antigen Levels as a Method For Prostate Cancer Detection
192 Citations1994Deborah S. Smith, William J. Catàlona
It is concluded that PSA slope is useful for serial prostate cancer screening, although its predictive value varies with patient age and initial PSA level.
PubMedInfluence of patient age on the serum PSA concentration. An important clinical observation.
147 Citations1993Joseph E. Oesterling, William H. Cooner +3 more
If one utilizes the age-specific reference ranges for serum PSA, it appears that PSAD can be eliminated as a parameter in the diagnostic evaluation of patients suspected of having prostate cancer.
CancerRelative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change
142 Citations1994Curtis Mettlin, Peter J. Littrup +6 more
There are data suggesting the usefulness of the PSA level relative to prostate gland volume, age‐referenced PSC level, and PSA change, and little research comparing the sensitivity and specificity of these measures in the same population has been reported.
CancerProstate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer
140 Citations1994Alan Pollack, Gunar K. Zagars +1 more
The relationship between PSA‐DT and the time to disease relapse after the onset of a rising PSA (PSA‐TTR) in 427 men treated in the PSAera with high dose radiotherapy for Stages T1–4 adenocarcinoma of the prostate was characterized.
The Journal of UrologyProstate Specific Antigen Levels in Men Older than 50 Years without Clinical Evidence of Prostatic Carcinoma
122 Citations1993Bruce L. Dalkin, Frederick R. Ahmann +1 more
The data support further attempts at using PSA, age and digital rectal examination to establish selection criteria for prostate biopsy with adequate sensitivity and specificity.
CA A Cancer Journal for CliniciansThe benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project
88 Citations1993Peter J. Littrup, Allen C. Goodman +1 more
Under the assumptions of these analyses, the combination of PSA and DRE appears to represent an ethical and economical detection choice for individual patients in consultation with their physicians.
CancerPredicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer
72 Citations1992Fred Lee, Peter J. Littrup +6 more
The diagnostic performance of transrectal ultrasound (TRUS) gland volume and prostate specific antigen (PSA) results were evaluated in 204 men consecutively scheduled to undergo transurethral prostatic resection (TUR).
JAMAWatchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences
58 Citations1988Michael J. Barry
CancerPrediction of pathologic stage and postprostatectomy disease recurrence by dna ploidy analysis of initial needle biopsy specimens of prostate cancer
56 Citations1994Jeffrey S. Ross, Helen L. Figge +5 more
The predictive value of ploidy status of cancers obtained by transrectal ultrasound‐guided needle biopsies in radical prostatectomy specimens has not been studied extensively.
Medical Decision MakingSymptom Severity and Patients' Values in the Decision to Perform a Transurethral Resection of the Prostate
38 Citations1988Peter E. Krumins, Stephan D. Fihn +1 more
This small study demonstrates the feasibility and validity of using value assessment in this setting and suggests that this approach can be useful to clinicians when counseling patients.
UrologyRelationship of tumor DNA-ploidy toserum prostate-specific antigen doubling time after radiotherapy for prostate cancer
29 Citations1994Alan Pollack, Gunar K. Zagars +2 more
It is confirmed that PSA-DT is a strong predictor of tumor behavior and that patients who have nondiploid tumors probably require more aggressive, combined modality, treatment.
PubMedClinical profile of stage D carcinoma of the prostate--a ten-year experience.
1 Citations1993Pierce K. H. Chow, Marcus Wong +1 more
The clinical profile of Stage D carcinoma of the prostate in the local population is established and acid and alkaline phosphatases were found to be poor diagnostic markers of the extent of the disease.